The UROONCO RCC editorial board chief editor Dr. Carmen Mir, and associate editors Dr. Teele Kuusk and Dr. Riccardo Bertolo share highlights of the important kidney cancer developments for 2024. They summarise the results on several important trials such as FASTRACK, ZIRCON, KEYNOTE-564 and IMmotion010. They also discuss the developments on surgical aspect ... Show More
Today
Functional Urology: To do or not to do urodynamics in this patient? That is the question…
When is urodynamic testing truly necessary, and when can it be avoided? How can clinicians make the right decision for each patient?In this episode, Prof. Enrico Finazzi Agrò (IT) is joined by Prof. Salvador Arlandis Guzmán (ES), Prof. Tufan Tarcan (TR) and Prof. Maurizio Serati ... Show More
34m 15s
Nov 1
Female mesh urinary complications: Update from EAU Section of Genitourinary Reconstructive Surgeons
How should female urinary mesh complications be assessed and managed, and what are the key considerations for treatment and long-term patient care?In this episode, Assoc. Prof. Tamsin Greenwell (GB) is joined by Dr. Eva Fong (NZ), Prof. Benoît Peyronnet (FR) and Dr. Tom Brits (BE ... Show More
33m 50s
Jul 2024
Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas
Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ... Show More
57m 23s
Feb 2024
Key Advances in Prostate, Kidney, and Bladder Cancers at GU24
<p>Drs. Neeraj Agarwal and Todd Morgan discuss CONTACT-02, KEYNOTE-564, CheckMate-67T, and other notable studies featured at the 2024 ASCO Genitourinary Cancers Symposium, as well as additional key abstracts in prostate, kidney, and bladder cancers that will significantly influen ... Show More
30m 6s
Mar 2024
Episode 171: ASCO-GU Top Clinical Data With Pedro Barata
Dr. Pedro Barata, Director of the Clinical Genitourinary Medical Oncology Research Program at UH Seidman Cancer Center, provides an exclusive round-up of the most groundbreaking and practice-changing research unveiled at the ASCO GU 2024 meeting. With expertise and insight, he de ... Show More
46m 7s
<p class="MsoNormal" style="text-align: justify;"><span class= "normaltextrun"><span style= "font-size: 11.0pt; line-height: 107%; font-family: 'Calibri',sans-serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-theme-font: major-fareast; mso-ansi-language: EN-US; mso-f ... Show More
